in-stent restenosis

FDA approves AGENT DCB for coronary artery disease patients

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary...
- Advertisement -spot_img

Latest News

Taylor Twellman discussed the Revolution’s playoff chances and the ongoing Everett stadium bid

New England Revolution The St. Louis native and former New England MVP also talked about Saturday's inaugural "Taylor Twellman Derby,"...
- Advertisement -spot_img